- Global Top Players in Intraocular Lens (IOL) Market
- How Robots Are Introducing A New Dimension To Healthcare Service Delivery
- Which Countries Top the Chart in Global Pharmaceutical Market?
- Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases
- How are Nanobots Proving Their Excellence in the Healthcare Industry?
- Most Promising Applications of Artificial Intelligence (AI) in Healthcare Segment
Warm Greetings from DelveInsight!
Dec 30, 2016 | Reading Time: < 1 minutes
Pharma M&A Rebound May Take a While in 2017
The only word that described 2016’s pharma M&A market was “slow.” Some do predict that new year—and administration—could revive energy in the deal making arena, the changes might not happen that fast. The reasons are aplenty, as shares have been sagging under the weight of investor fears of drug-pricing reform. ...Find More
LEQEMBI Intravenous Infusion Approval; Novartis’ Presented Updates on Lutathera; FDA Accepts Submission to Add PH-ILD to YUTREPIA Label; FDA Issues CRL to BLA for Pegfilgrastim-cbqv; FDA Fast Track Designation to Therpay, MWTX-003; EC Approves TEPKINLY (epcoritamab) for R/R DLBCL
Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera On Sept. 20, 2023, Disc Medicine, Inc. (NASDAQ: IRON) announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to MWTX-003 for the treatment of patients with Polycyt...Find More
Orchard’s OTL-200 to Enter US Metachromatic Leukodystrophy Treatment Space After EU
Orchard Therapeutics’ Biologics License Application for OTL-200, a gene therapy under investigation for metachromatic leukodystrophy treatment, has been accepted by the FDA. This rare disease treatment received approval in Europe back in 2020. Notably, the FDA has granted Orchard’s application Priority Review statu...Find More
ASCO Conference 2023
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.